Photodynamic therapy and anti-tumour immunity

Nat Rev Cancer. 2006 Jul;6(7):535-45. doi: 10.1038/nrc1894.

Abstract

Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Combined Modality Therapy
  • Humans
  • Immunotherapy*
  • Inflammation / immunology
  • Lymphocyte Activation / immunology
  • Neoplasms / immunology*
  • Neoplasms / therapy*
  • Photochemotherapy*
  • T-Lymphocytes / immunology